In addition, PIPKIα and IPMK expression was significantly elevated and correlated with CTGF expression in breast cancer clinical samples, making PIPKIα and IPMK promising drug targets in YAP/TAZ-driven breast and other cancers. Here, CCN2 is linked to breast carcinoma.